Pipeline
Candidate
Indication
Pre-Clinical
Phase 1
Phase 2
Phase 3
NTS-104 intravenous
Acute Ischemic Stroke (AIS)
Lead Indication
Lead Indication
Chronic Stroke
Next Generation Candidate subcutaneous /
intramuscular
intramuscular
Acute Ischemic & Chronic Stroke
Expansion Indications